Financhill
Back

BlackRock Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
64

BLK
BlackRock

Last Price:
788.02
Seasonality Move:
5.13%
Sell
38

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Buy
64
BlackRock (BLK) is a Buy

Is BlackRock a Buy, Sell or Hold?

  • The current BlackRock [BLK] share price is $782.83. The Score for BLK is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • BLK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $38.02. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BLK Stock Price Chart

What is BlackRock's stock price today?

  • The BlackRock share price today is $782.83
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BLK is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $38.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

BLK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.62 Sell
Relative Strength Index (14 RSI): 52.78 Buy
Chaikin Money Flow: 311163 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (765.48 - 798.76) Buy
Bollinger Bands (100): (767.74 - 815.56) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 40.05 Sell
Chaikin Money Flow: 76134 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.06 - 42.34) Sell
Bollinger Bands (100): (41.13 - 48.85) Sell

BLK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 772.56 Buy
20-day SMA: 775.36 Buy
50-day SMA: 775.22 Buy
200-day SMA: 751.52 Buy
8-day EMA: 776.89 Buy
20-day EMA: 777.25 Buy
50-day EMA: 781.12 Buy
200-day EMA: 761.15 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.68 Sell
20-day SMA: 40.48 Sell
50-day SMA: 42.18 Sell
200-day SMA: 42.45 Sell
8-day EMA: 39.81 Sell
20-day EMA: 40.64 Sell
50-day EMA: 42.13 Sell
200-day EMA: 43.5 Sell

BlackRock Earnings Growth & BLK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.07 per share, an increase next quarter of $1.04 per share, an increase this year of $4.31 per share, and an increase next year of $5.31 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

BlackRock Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):